Alsonex will attend the BIO International Convention 2026 (BIO26), held 22–25 June 2026 at the San Diego Convention Center in San Diego, California. The convention brings together biotechnology and pharmaceutical companies, investors and partners from across the global industry, and offers an opportunity for the company to introduce its complement-targeting programme in neurodegenerative disease and its lead compound, ALS-205, in development for Motor Neuron Disease (MND/ALS).
Paul Field will represent Alsonex at the convention and welcomes the chance to meet with prospective partners and investors. Those interested in arranging a meeting, or in learning more about the company’s research, are invited to make contact through the company’s contact page.